CLOS
Compagnie Lombard Odier SCmA’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53M | Sell |
51,085
-12,145
| -19% | -$838K | 0.05% | 105 |
|
|
2025
Q1 | $4.39M | Sell |
63,230
-4,515
| -7% | -$314K | 0.05% | 108 |
|
|
2024
Q4 | $5.83M | Buy |
67,745
+3,200
| +5% | +$275K | 0.09% | 93 |
|
|
2024
Q3 | $7.69M | Buy |
64,545
+800
| +1% | +$95.3K | 0.12% | 83 |
|
|
2024
Q2 | $9.1M | Sell |
63,745
-85
| -0.1% | -$12.1K | 0.15% | 76 |
|
|
2024
Q1 | $8.2M | Buy |
63,830
+7,255
| +13% | +$932K | 0.15% | 88 |
|
|
2023
Q4 | $5.85M | Buy |
56,575
+8,665
| +18% | +$896K | 0.11% | 96 |
|
|
2023
Q3 | $4.36M | Buy |
47,910
+24,655
| +106% | +$2.24M | 0.1% | 98 |
|
|
2023
Q2 | $3.76M | Buy |
23,255
+11,005
| +90% | +$1.78M | 0.11% | 87 |
|
|
2023
Q1 | $1.95M | Buy |
12,250
+6,491
| +113% | +$1.03M | 0.05% | 130 |
|
|
2022
Q4 | $780K | Sell |
5,759
-600
| -9% | -$81.3K | 0.02% | 165 |
|
|
2022
Q3 | $634K | Buy |
+6,359
| New | +$634K | 0.02% | 194 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$6K | – | 620 |
|
|
2017
Q4 | $6K | Sell |
100
-22,800
| -100% | -$1.37M | ﹤0.01% | 603 |
|
|
2017
Q3 | $1.1M | Hold |
22,900
| – | – | 0.04% | 206 |
|
|
2017
Q2 | $982K | Sell |
22,900
-1,400
| -6% | -$60K | 0.03% | 221 |
|
|
2017
Q1 | $833K | Buy |
+24,300
| New | +$833K | 0.03% | 233 |
|